Medical Tests
Explore lab tests, blood work, and imaging exams with plain-language preparation and overview pages.
Browse Directory Sections
Tests starting with I (5,164)
Other
IRF-PAI v3.0, MDS v1.17.1, 1.17.2, OASIS E - Self-care - discharge goal during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Administrative information - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Administrative information during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Cognitive patterns - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Cognitive patterns - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Health conditions - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Hearing, speech, and vision - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Identification information during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Quality indicators - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Quality indicators - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Special treatments, procedures, and programs - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Swallowing/nutritional status - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00 - Medications - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00 - Medications - discharge and expired during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00 - Nutritional approaches - last 7D and discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00 - Swallowing/nutritional status - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC during assessment period [CMS Assessment]
Other
IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - discharge during assessment period [CMS Assessment]
Other
IRF-PAIv3.0, MDS v1.17.1, 1.17.2 - Self-care - discharge performance during assessment period [CMS Assessment]
Blood test
IRF6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
ISCN band level [#] Qualitative
Other
ISCN band level [#] in Amniotic fluid Qualitative by Molecular genetics method
Other
ISCN band level [#] in Chorionic villus sample Qualitative by Molecular genetics method
Blood test
ISOtretinoin [Mass/volume] in Serum or Plasma
Blood test
ISOtretinoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Blood test
ISOtretinoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Blood test
ITGA2B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ITGB3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ITGB3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Blood test
ITPA gene g.9330C>A [Type] in Serum or Plasma by Molecular genetics method
Blood test
ITPA gene g.9381A>C [Type] in Serum or Plasma by Molecular genetics method
Other
IV contrast given [Identifier]
Other
IV contrast given [Volume]
Other
IV medication [Minimum Data Set]
Other
IV medications in last 14 days - while a resident [MDSv3]
Other
IV medications in last 14 days - while not a resident [MDSv3]
Other
IV number [Identifier]
Other
IV site NEMSIS
Blood test
IVD gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
IVD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
Ibuprofen IgE Ab [Units/volume] in Serum
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --1 hour post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --1.5 hours post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --2 hours post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --2.5 hours post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --3 hours post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --30 minutes post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --pre dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma by Screen method
Other
Ibuprofen [Mass/volume] in Urine
Other
Ibuprofen [Mass] of Dose
Blood test
Ibuprofen [Measurement] in Serum or Plasma
Other
Ibuprofen [Measurement] in Urine
Other
Ibuprofen [Moles/volume] in Gastric fluid
Blood test
Ibuprofen [Moles/volume] in Serum or Plasma
Other
Ibuprofen [Moles/volume] in Specimen
Other
Ibuprofen [Moles/volume] in Urine
Blood test
Ibuprofen [Presence] in Serum or Plasma
Other
Ibuprofen [Presence] in Urine
Blood test
Ibuprofen induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Blood test
Ibuprofen induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Blood test
Ibuprofen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Blood test
Ibuprofen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Blood test
Ibuprofen triggered leukotriene release [Mass/volume] by Leukocytes
Other
Iclaprim [Susceptibility]
Other
Iclaprim [Susceptibility] by Disk diffusion (KB)
Other
Iclaprim [Susceptibility] by Minimum inhibitory concentration (MIC)
Other
Icteric interference index of Cerebral spinal fluid
Blood test
Icteric interference index of Serum or Plasma
Other
Icteric interference index of Urine
Other
Ideal body weight
Other
Ideal erythrocyte [Volume] by calculation
Other
Ideal plasma [Volume] by calculation
Other
Ideal volume by calculation
Other
Identification and background information section
Other
Identification information
Other
Identification information section
Other
Identification {Tooth}
Other
Identification {Tooth} Best estimate
Other
Identification {Tooth} Observed
Other
Identification {Tooth} XR
Other
Identified based on transfusion investigation post blood product donation
Other
Identifier Clinical trial protocol
Other
Identifier and Assigning authority panel
Other
Identifying information Narrative Observed
Other
Identity testing [Identifier] in Index case from Comparison case by Molecular genetics method Narrative
Other
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Fibroblast
Blood test
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Leukocytes
Other
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Tissue
Other
Iduronate-2-Sulfatase [Enzymatic activity/volume] in DBS
Blood test
Iduronate-2-Sulfatase [Enzymatic activity/volume] in Serum or Plasma
Other
If I am in trouble, I can usually think of a solution [GSE]
Other
If I feel like doing something, I tend to do it, even if it's bad [UPPS-R-Child]
Other
If I hurry or walk fast, I have to stop or slow down [PhenX]